Likewise, ectopic expression of the genetic components of peptide-MHC complexes has the potential to redirect the cytotoxicity of neoantigen vaccine-primed immunity towards tumor cells beyond the resident cells of neoantigens to broaden the applicability of neoantigen vaccines. The gene discussed is HLA-C; the disease is neoplasm.